- Home
- REPL vs DNUT Comparison
REPL vs DNUT Comparison
Compare REPL & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- DNUT
- Stock Information
- Founded
- REPL 2015
- DNUT 1937
- Country
- REPL United States
- DNUT United States
- Employees
- REPL N/A
- DNUT N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- DNUT Food Chains
- Sector
- REPL Health Care
- DNUT Consumer Staples
- Exchange
- REPL Nasdaq
- DNUT Nasdaq
- Market Cap
- REPL 547.0M
- DNUT 578.7M
- IPO Year
- REPL 2018
- DNUT 2021
- Fundamental
- Price
- REPL $5.80
- DNUT $3.14
- Analyst Decision
- REPL Hold
- DNUT Buy
- Analyst Count
- REPL 9
- DNUT 6
- Target Price
- REPL $7.00
- DNUT $6.22
- AVG Volume (30 Days)
- REPL 2.5M
- DNUT 3.6M
- Earning Date
- REPL 11-11-2025
- DNUT 11-06-2025
- Dividend Yield
- REPL N/A
- DNUT 3.33%
- EPS Growth
- REPL N/A
- DNUT N/A
- EPS
- REPL N/A
- DNUT N/A
- Revenue
- REPL N/A
- DNUT $1,538,841,000.00
- Revenue This Year
- REPL N/A
- DNUT N/A
- Revenue Next Year
- REPL $408.25
- DNUT $2.93
- P/E Ratio
- REPL N/A
- DNUT N/A
- Revenue Growth
- REPL N/A
- DNUT N/A
- 52 Week Low
- REPL $2.68
- DNUT $2.50
- 52 Week High
- REPL $17.00
- DNUT $12.68
- Technical
- Relative Strength Index (RSI)
- REPL 47.90
- DNUT 40.96
- Support Level
- REPL $5.74
- DNUT $2.95
- Resistance Level
- REPL $6.15
- DNUT $3.58
- Average True Range (ATR)
- REPL 0.35
- DNUT 0.18
- MACD
- REPL 0.12
- DNUT -0.05
- Stochastic Oscillator
- REPL 41.03
- DNUT 20.11
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.